25/04/2015 00:19:55 Free Membership Login

Mylan N.V. News (NASDAQ:MYL)

DateTimeSource
Headline
04/24/20153:59PMDJNMylan Raises Bid for Generic Drug Maker Perrigo -- 6th Update
By Angela Chen Mylan NV raised its offer to buy generic drug maker Perrigo Co. to about $33 billion and was promptly rebuffed, the latest moves in a three-way takeover tussle in the pharmaceutical industry. Mylan's bid consists of $60 in cash and 2.2 Mylan shares for each share of Perrigo. Based on Thursday's close, the... More...>>
04/24/20151:04PMDJNMylan Raises Bid for Generic Drug Maker Perrigo -- 5th Update
By Angela Chen Mylan NV raised its offer to buy generic drug maker Perrigo Co. to about $33 billion and was promptly rebuffed, the latest moves in a three-way takeover tussle in the pharmaceutical industry. Mylan's bid consists of $60 in cash and 2.2 Mylan shares for each share of Perrigo. Based on Thursday's close, the... More...>>
04/24/201512:16PMDJNMylan Raises Bid for Generic Drug Maker Perrigo -- 4th Update
By Angela Chen Mylan NV raised its offer to buy generic drug maker Perrigo Co. to about $33 billion, the latest move in a three-way takeover tussle in the pharmaceutical industry. Mylan, which saw an earlier offer spurned by Perrigo this week, said its latest bid consists of $60 in cash and 2.2 Mylan shares for each share... More...>>
04/24/201512:09PMPRNUSPerrigo Rejects Mylan Unsolicited Offer
Perrigo Rejects Mylan Unsolicited Offer Offer Significantly Below Prior Proposal Based on Unaffected Mylan Stock Price Shareholders are Strongly Advised to Take No Action in Relation to the Offer PR Newswire DUBLIN, April 24, 2015 DUBLIN, April 24, 2015 /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company... More...>>
04/24/201511:21AMDJNMylan to Make Formal Bid for Perrigo -- 3rd Update
By Angela Chen Mylan NV said it will make a formal offer, worth about $33 billion in cash and stock, to buy generic drug maker Perrigo Co., the latest move in a three-way takeover tussle in the pharmaceutical industry. Mylan, which had indicated earlier this month that it was considering such a bid, said its offer consists... More...>>
04/24/201511:11AMDJNMylan to Make Formal Bid for Perrigo -- 2nd Update
By Angela Chen Mylan NV said it will make a formal offer, worth about $33 billion in cash and stock, to buy generic drug maker Perrigo Co., the latest move in a three-way takeover tussle in the pharmaceutical industry. Mylan, which had indicated earlier this month that it was considering such a bid, said its offer consists... More...>>
04/24/201510:51AMDJNMylan to Make Formal Bid for Perrigo -- Update
By Angela Chen Mylan NV said it will make a formal offer, worth about $33 billion in cash and stock, to buy generic drug maker Perrigo Co., the latest move in a three-way takeover tussle. Mylan, which had indicated earlier this month that it was considering such a bid, said its offer consists of $60 in cash and 2.2 Mylan... More...>>
04/24/201510:50AMDJNMylan to Make Formal Bid for Perrigo
Mylan NV said it will launch a formal offer worth about $33 billion in cash and stock to buy generic drug maker Perrigo Co. Mylan, which had indicated earlier this month that it was considering such a bid, said its offer consists of $60 in cash and 2.2 Mylan shares for each share of Perrigo. Based on Thursday's close... More...>>
04/24/201510:36AMDJNMylan to Make Formal Bid for Perrigo
By Angela Chen Mylan NV said it will launch a formal offer worth about $33 billion in cash and stock to buy generic drug maker Perrigo Co. Mylan, which had indicated earlier this month that it was considering such a bid, said its offer consists of $60 in cash and 2.2 Mylan shares for each share of Perrigo. Based on Thursday's... More...>>
04/24/20159:44AMPRNUSMylan To Commence Formal Offer To Acquire Perrigo For US$60 In Cash And 2.2 Mylan Shares Per Perrigo Share
Mylan To Commence Formal Offer To Acquire Perrigo For US$60 In Cash And 2.2 Mylan Shares Per Perrigo Share THE DISTRIBUTION OF THIS COMMUNICATION IN CERTAIN JURISDICTIONS MAY BE RESTRICTED OR AFFECTED BY THE LAWS OF SUCH JURISDICTIONS. ACCORDINGLY, COPIES OF THIS COMMUNICATION ARE NOT BEING, AND MUST NOT BE, MAILED OR... More...>>
04/24/20159:30AMARNMylan NV PT Raised to $82.00 at Deutsche Bank (MYL)
http://tickerreport.com/banking-finance/472028/mylan-nv-pt-raised-to-82-00-at-deutsche-bank-myl/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
04/23/20155:00AMPRNUSMylan Launches Generic Sofosbuvir Tablets, MyHep™, in India
Mylan Launches Generic Sofosbuvir Tablets, MyHep™, in India PR Newswire POTTERS BAR, England and HYDERABAD, India, April 23, 2015 POTTERS BAR, England and HYDERABAD, India, April 23, 2015 /PRNewswire/ -- Mylan N.V. (Nasdaq: MYL) today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched... More...>>
04/22/20159:17PMDJNMeet Pharma's Newest Movers and Shakers, Driving M&A
By Jonathan D. Rockoff And Joseph Walker A few years ago, the drug companies dominating mergers-and-acquisitions headlines were largely household names, from Pfizer Inc. and Merck & Co. to Novartis AG. These days, a new generation of deal makers is making news, with names distinctly less familiar: Actavis PLC, Endo... More...>>
04/22/20158:12PMDJNMeet Pharma's Newest Movers and Shakers, Driving M&A
By Jonathan D. Rockoff And Joseph Walker A few years ago, the drug companies dominating mergers-and-acquisitions headlines were largely household names, from Pfizer Inc. and Merck & Co. to Novartis AG. These days, a new generation of deal makers is making news, with names distinctly less familiar: Actavis PLC, Endo... More...>>
04/22/201512:45PMDJNThe Rise of the 'Stichting,' an Obscure Takeover Defense
By Shayndi Raice And Margot Patrick LONDON--A centuries-old Dutch legal structure that has become a popular self-defense tool for companies and wealthy individuals could play a leading role in a takeover battle now shaping up. Israel's Teva Pharmaceutical Industries Ltd. said Tuesday it is bidding $40 billion for Mylan... More...>>
04/22/201511:50AMDJNThe Rise of the 'Stichting,' an Obscure Takeover Defense
By Shayndi Raice And Margot Patrick LONDON--A centuries-old Dutch legal structure that has become a popular self-defense tool for companies and wealthy individuals could play a leading role in a takeover battle now shaping up. Israel's Teva Pharmaceutical Industries Ltd. said Tuesday it is bidding $40 billion for Mylan... More...>>
04/22/201510:49AMARNCRT Capital Increases Mylan NV Price Target to $87.00 (MYL)
http://tickerreport.com/banking-finance/466513/crt-capital-increases-mylan-nv-price-target-to-87-00-myl/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
04/22/201510:10AMDJNAbbott Labs Reports Better-Than-Expected Profit
Abbott Laboratories on Wednesday said its first-quarter earnings rose, thanks largely to a gain stemming from recent divestitures, although currency fluctuations weighed on sales growth. The company said the stronger dollar shaved 7% from its top line. The Illinois-based health-care company has been realigning its business... More...>>
04/22/20159:46AMDJNAbbott Labs Reports Better-Than-Expected Profit -- Update
By Lisa Beilfuss Abbott Laboratories on Wednesday said its first-quarter earnings rose, thanks largely to a gain stemming from recent divestitures, although currency fluctuations weighed on sales growth. The company said the stronger dollar shaved 7% from its top line. The Illinois-based health-care company has been realigning... More...>>
04/22/20159:37AMDJNAbbott Labs Reports Better-Than-Expected Profit
By Lisa Beilfuss Abbott Laboratories on Wednesday said its first-quarter earnings rose, thanks largely to a gain stemming from recent divestitures, although currency fluctuations weighed on sales growth. The company said the stronger dollar shaved 7% from its top line. The Illinois-based health-care company has been realigning... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq myl150425 00:19